Cargando…
Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report
INTRODUCTION: Drug-induced fever is easy to overlook in respiratory departments. High fever is a rare side effect of trihexyphenidyl, which can be used clinically to treat Parkinson's disease. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a group of clinical syndromes caus...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254568/ https://www.ncbi.nlm.nih.gov/pubmed/32443324 http://dx.doi.org/10.1097/MD.0000000000020129 |
_version_ | 1783539566803681280 |
---|---|
author | Zhao, Jun Xu, Gang Feng, Congrui Chen, Yuluo Kang, Yanhong Liu, Feng Ma, Wei |
author_facet | Zhao, Jun Xu, Gang Feng, Congrui Chen, Yuluo Kang, Yanhong Liu, Feng Ma, Wei |
author_sort | Zhao, Jun |
collection | PubMed |
description | INTRODUCTION: Drug-induced fever is easy to overlook in respiratory departments. High fever is a rare side effect of trihexyphenidyl, which can be used clinically to treat Parkinson's disease. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a group of clinical syndromes caused by various diseases, resulting in water retention and refractory hyponatremia. However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported. We describe an unusual case of malignant hyperthermia and refractory hyponatremia due to trihexyphenidyl adverse reaction. PATIENT CONCERNS: Fifty-five-year-old male with pneumonia presented with malignant hyperthermia and refractory hyponatremia has a history of Parkinson's disease. DIAGNOSIS: Early considerations related the described hyperthermia findings to the manifestations of pneumonia. However, the last findings were due to trihexyphenidyl adverse reaction. INTERVENTIONS: Broad-spectrum antibiotics, oral and intravenous supplement of concentrated sodium chloride, drug, and physical cooling. OUTCOMES: The patient survived. During the 3-month follow up, the patient was no recurrence of fever or hyponatremia. CONCLUSION: High fever and SIADH can be a rare adverse reaction to trihexyphenidyl. Therefore, possible drug factors should be considered in the case. Consideration of other possible causes can improve early diagnosis and treatment of patients with fever of unknown origins. |
format | Online Article Text |
id | pubmed-7254568 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-72545682020-06-15 Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report Zhao, Jun Xu, Gang Feng, Congrui Chen, Yuluo Kang, Yanhong Liu, Feng Ma, Wei Medicine (Baltimore) 4200 INTRODUCTION: Drug-induced fever is easy to overlook in respiratory departments. High fever is a rare side effect of trihexyphenidyl, which can be used clinically to treat Parkinson's disease. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a group of clinical syndromes caused by various diseases, resulting in water retention and refractory hyponatremia. However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported. We describe an unusual case of malignant hyperthermia and refractory hyponatremia due to trihexyphenidyl adverse reaction. PATIENT CONCERNS: Fifty-five-year-old male with pneumonia presented with malignant hyperthermia and refractory hyponatremia has a history of Parkinson's disease. DIAGNOSIS: Early considerations related the described hyperthermia findings to the manifestations of pneumonia. However, the last findings were due to trihexyphenidyl adverse reaction. INTERVENTIONS: Broad-spectrum antibiotics, oral and intravenous supplement of concentrated sodium chloride, drug, and physical cooling. OUTCOMES: The patient survived. During the 3-month follow up, the patient was no recurrence of fever or hyponatremia. CONCLUSION: High fever and SIADH can be a rare adverse reaction to trihexyphenidyl. Therefore, possible drug factors should be considered in the case. Consideration of other possible causes can improve early diagnosis and treatment of patients with fever of unknown origins. Wolters Kluwer Health 2020-05-15 /pmc/articles/PMC7254568/ /pubmed/32443324 http://dx.doi.org/10.1097/MD.0000000000020129 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4200 Zhao, Jun Xu, Gang Feng, Congrui Chen, Yuluo Kang, Yanhong Liu, Feng Ma, Wei Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report |
title | Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report |
title_full | Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report |
title_fullStr | Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report |
title_full_unstemmed | Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report |
title_short | Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report |
title_sort | trihexyphenidyl induced malignant hyperthermia in a patient with parkinson's disease complicated with pneumonia: a case report |
topic | 4200 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254568/ https://www.ncbi.nlm.nih.gov/pubmed/32443324 http://dx.doi.org/10.1097/MD.0000000000020129 |
work_keys_str_mv | AT zhaojun trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport AT xugang trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport AT fengcongrui trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport AT chenyuluo trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport AT kangyanhong trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport AT liufeng trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport AT mawei trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport |